NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/29/2022
Back to search
Official data from USPTO
MACROFINDER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MACROFINDER
ST13
US500000079077372Class
1, 5, 42
Filing
79077372
Registration
3950034
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
10/29/2022
Trademark type
Word
Nice classes
1, 5, 42
Filing date
10/29/2009
Registration date
04/26/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2021
Last transaction
11/26/2021
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Allschwil, CH
Examiner
KING, LINDA M
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Polyphor AG
Representatives
Scott D. Woldow Smith, Gambrell, Russell, LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industry and science
Class 5
Pharmaceutical anti-allergic preparations and substancesPharmaceutical for the treatment of erectile dysfunctionPharmaceutical preparationsanticoagulantsPharmaceutical preparationsantidepressantsPharmaceutical preparationsappetite suppressantsPharmaceutical preparations for use in chemotherapyPharmaceutical preparation for the treatment of goutPharmaceutical preparations for the treatment of heart rhythm disordersPharmaceutical preparations for the treatment of stem cell mobilizationPharmaceutical preparations for the treatment of infectious diseasesPharmaceutical preparations acting on the central nervous systemPharmaceutical preparations and substances for the treatment of gastro-intestinal diseasesPharmaceutical preparations for animal skincarePharmaceutical preparations for inhalation for the treatment of pulmonary hypertensionPharmaceutical preparations for ocular or intraocular surgeryPharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosisPharmaceutical preparations for treating allergic rhinitis and asthmaPharmaceutical preparations for treating diabetesPharmaceutical preparations for treating skin disordersPharmaceutical preparations for use in dermatologyPharmaceutical preparations for woundsPharmaceutical preparations for use in urologyPharmaceutical preparationsa blood clotting aid and delivery system for use in humansPharmaceutical products and preparations against dry skin caused by pregnancyPharmaceutical products and preparations for chloasmaPharmaceutical products and preparations for hydrating the skin during pregnancyPharmaceutical products and preparations for pregnancy blemishesPharmaceutical products and preparations for preventing skin blemishes during pregnancyPharmaceutical products and preparations to prevent stretch marksPharmaceutical products and preparations to prevent swelling in the legsPharmaceutical products for ophthalmological usePharmaceutical products for the treatment of bone diseasesPharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancerPharmaceutical products for treating respiratory diseases and asthmaPharmaceutical skin lotionsPharmaceutical solutions used in dialysisPharmaceuticals for the treatment of erectile dysfunctionPharmaceuticalsantihelminticsPharmaceuticalsinducers of erectionsPharmaceuticalslipid lowering agentsPharmaceuticalspsychotropicsPharmaceuticalsanti-infectives; and sanitary preparations for medical purposes; dietetic foods adapted for medical usemedical plastersdressings for woundsburnssurgery; dental impression materials; disinfectants for hygienic purposes
Class 42
Scientific and technological services in the nature of scientific research in the fields of pharmaceuticals and bio-chemistry ; design for others in the fields of pharmaceuticals and bio-chemistry; industrial analysis and research services in the fields of pharmaceuticals and bio-chemistry
Publications
History of USPTO decisions and trademark events.
52 publications found
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
09/19/2022
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/29/2022
INPC
INVALIDATION PROCESSED
08/29/2022
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
07/26/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2022
C71T
CANCELLED SECTION 71
11/26/2021
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
04/26/2020
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/05/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/19/2018
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
04/06/2018
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
02/22/2018
INPC
INVALIDATION PROCESSED
02/22/2018
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
02/21/2018
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/21/2017
71AG
REGISTERED-SEC.71 ACCEPTED
06/21/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/20/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/19/2017
ES71
TEAS SECTION 71 RECEIVED
04/18/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/14/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/21/2011
FIMP
FINAL DISPOSITION PROCESSED
09/21/2011
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/26/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
04/26/2011
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/19/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/08/2011
PUBO
PUBLISHED FOR OPPOSITION
02/08/2011
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/03/2011
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/03/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/04/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/30/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/30/2010
ALIE
ASSIGNED TO LIE
12/22/2010
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/19/2010
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/30/2010
GNFR
FINAL REFUSAL E-MAILED
07/30/2010
CNFR
FINAL REFUSAL WRITTEN
07/30/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/15/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/15/2010
ALIE
ASSIGNED TO LIE
07/15/2010
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/29/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/29/2010
RFNT
REFUSAL PROCESSED BY IB
03/05/2010
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/08/2010
RFRR
REFUSAL PROCESSED BY MPU
02/08/2010
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/05/2010
CNRT
NON-FINAL ACTION WRITTEN
02/04/2010
DOCK
ASSIGNED TO EXAMINER
02/03/2010
MAFR
APPLICATION FILING RECEIPT MAILED
01/26/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/22/2010
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/21/2010
Continuous trademark protection
Get notified about every new filing that threatens MACROFINDER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.